Cipla reported 140.5M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Cipla 140.5M 300K Jun/2025
Dr.Reddys Laboratories 830M 174M Jun/2025
Life Technologies 0 0 Sep/2024
Sun Pharmaceuticals 748M 256.6M Jun/2025
UPL 9.14B 1.84B Mar/2025